Prospects for combining targeted and conventional cancer therapy with immunotherapy
Novartis Institutes for BioMedical Research · Novartis (Switzerland)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
965
total citations
- FWCI
- 46.69
- Percentile
- 100%
- References
- 190
Citations per year
Authors
12- PJPhilip J. GotwalsCorresponding
Novartis Institutes for BioMedical Research, Novartis (Switzerland)
- SBScott B. Cameron
Novartis Institutes for BioMedical Research, Novartis (Switzerland)
- DCDaniela Cipolletta
Novartis (Switzerland), Novartis Institutes for BioMedical Research
- VCViviana Cremasco
Novartis Institutes for BioMedical Research, Novartis (Switzerland)
- ACAdam Crystal
Novartis (Switzerland), Novartis Institutes for BioMedical Research
Topics & keywords
Topics
Keywords
- Medicine
- Immunotherapy
- Radiation therapy
- Cancer
- Immune system
- Immunity
- Targeted therapy
- Immunology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.